BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Marvin 2D Structure

The following exact ligands are found in BindingDB

Wt: 1890.2
BDBM50205094

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)

Found 4 hits in this display   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50205094
PNG
((S)-2-((S)-2-((2S,3R)-2-((S)-2-((S)-2-((S)-2-((S)-...)
Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(N)=O |wU:4.4,78.81,45.46,95.96,23.22,61.62,115.116,77.78,wD:33.33,12.11,84.85,53.54,104.105,69.70,127.129,(-16.44,-20.9,;-16.44,-22.44,;-15.11,-23.21,;-17.79,-23.21,;-17.79,-24.75,;-19.12,-25.52,;-20.46,-24.75,;-21.79,-25.52,;-20.46,-23.21,;-16.44,-25.52,;-16.44,-27.06,;-15.12,-24.73,;-13.8,-25.51,;-13.8,-27.05,;-12.45,-27.82,;-12.45,-29.36,;-11.11,-30.11,;-11.12,-31.65,;-12.47,-32.41,;-9.78,-32.42,;-12.45,-24.74,;-12.45,-23.2,;-11.11,-25.49,;-9.77,-24.73,;-9.77,-23.19,;-8.43,-22.42,;-7.03,-23.06,;-5.99,-21.91,;-6.76,-20.58,;-8.27,-20.89,;-8.43,-25.5,;-8.43,-27.04,;-7.11,-24.71,;-5.78,-25.48,;-5.78,-27.02,;-4.44,-27.79,;-3.11,-27.02,;-1.78,-27.79,;-1.78,-29.33,;-.46,-30.08,;-3.11,-30.1,;-4.44,-29.33,;-4.44,-24.71,;-4.44,-23.17,;-3.11,-25.48,;-1.77,-24.71,;-1.77,-23.17,;-.43,-22.4,;-.43,-20.86,;.91,-23.17,;-.43,-25.48,;-.43,-27.02,;.9,-24.71,;2.23,-25.49,;2.23,-27.03,;3.56,-27.8,;4.9,-27.01,;3.56,-29.34,;3.56,-24.72,;3.56,-23.18,;4.9,-25.48,;6.24,-24.71,;6.24,-23.17,;7.58,-22.4,;7.58,-20.86,;8.91,-23.17,;7.58,-25.48,;7.58,-27.02,;8.91,-24.72,;10.25,-25.49,;10.24,-27.03,;11.58,-27.81,;11.57,-29.35,;12.91,-27.04,;11.58,-24.72,;11.58,-23.18,;12.92,-25.49,;14.25,-24.73,;14.25,-23.19,;12.92,-22.42,;15.55,-22.39,;15.59,-25.5,;15.59,-27.04,;16.91,-24.7,;18.23,-25.48,;18.23,-27.02,;19.57,-27.79,;19.57,-29.33,;20.91,-30.09,;20.94,-31.63,;19.57,-32.37,;22.25,-32.38,;19.57,-24.71,;19.57,-23.17,;20.91,-25.47,;22.26,-24.72,;22.26,-23.18,;23.6,-22.41,;23.6,-20.87,;22.25,-20.08,;24.93,-20.1,;23.6,-25.49,;23.6,-27.03,;24.92,-24.71,;26.25,-25.49,;26.25,-27.03,;27.59,-27.8,;27.59,-29.34,;28.93,-30.1,;28.94,-31.64,;27.59,-32.39,;30.27,-32.4,;27.59,-24.72,;27.59,-23.18,;28.92,-25.49,;30.26,-24.72,;30.26,-23.18,;31.6,-22.41,;32.93,-23.18,;34.26,-22.41,;34.26,-20.87,;35.6,-20.1,;32.93,-20.1,;31.6,-20.87,;31.6,-25.49,;31.6,-27.03,;32.93,-24.72,;34.26,-25.49,;34.26,-27.03,;35.6,-27.8,;35.59,-24.72,;36.93,-25.49,;35.59,-23.18,)|
Show InChI InChI=1S/C84H136N28O20S/c1-41(2)30-56(99-46(10)114)73(124)101-53(15-12-28-96-83(90)91)71(122)109-62(36-49-38-94-40-98-49)78(129)108-60(34-47-17-21-50(115)22-18-47)76(127)104-58(32-43(5)6)75(126)110-63(37-66(86)118)79(130)105-57(31-42(3)4)74(125)106-59(33-44(7)8)80(131)112-67(45(9)113)81(132)103-54(16-13-29-97-84(92)93)69(120)102-55(25-26-65(85)117)72(123)100-52(14-11-27-95-82(88)89)70(121)107-61(35-48-19-23-51(116)24-20-48)77(128)111-64(39-133)68(87)119/h17-24,38,40-45,52-64,67,113,115-116,133H,11-16,25-37,39H2,1-10H3,(H2,85,117)(H2,86,118)(H2,87,119)(H,94,98)(H,99,114)(H,100,123)(H,101,124)(H,102,120)(H,103,132)(H,104,127)(H,105,130)(H,106,125)(H,107,121)(H,108,129)(H,109,122)(H,110,126)(H,111,128)(H,112,131)(H4,88,89,95)(H4,90,91,96)(H4,92,93,97)/t45-,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,64+,67+/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
200n/an/an/an/an/an/an/an/a



Bayer Pharmaceuticals Corporation

Curated by ChEMBL


Assay Description
Displacement of [125I]PYY from human NPY2 receptor in KAN-TS cells by SPA assay


Bioorg Med Chem Lett 17: 1916-9 (2007)


Article DOI: 10.1016/j.bmcl.2007.01.045
BindingDB Entry DOI: 10.7270/Q2WW7HB0
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 5


(Homo sapiens (Human))
BDBM50205094
PNG
((S)-2-((S)-2-((2S,3R)-2-((S)-2-((S)-2-((S)-2-((S)-...)
Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(N)=O |wU:4.4,78.81,45.46,95.96,23.22,61.62,115.116,77.78,wD:33.33,12.11,84.85,53.54,104.105,69.70,127.129,(-16.44,-20.9,;-16.44,-22.44,;-15.11,-23.21,;-17.79,-23.21,;-17.79,-24.75,;-19.12,-25.52,;-20.46,-24.75,;-21.79,-25.52,;-20.46,-23.21,;-16.44,-25.52,;-16.44,-27.06,;-15.12,-24.73,;-13.8,-25.51,;-13.8,-27.05,;-12.45,-27.82,;-12.45,-29.36,;-11.11,-30.11,;-11.12,-31.65,;-12.47,-32.41,;-9.78,-32.42,;-12.45,-24.74,;-12.45,-23.2,;-11.11,-25.49,;-9.77,-24.73,;-9.77,-23.19,;-8.43,-22.42,;-7.03,-23.06,;-5.99,-21.91,;-6.76,-20.58,;-8.27,-20.89,;-8.43,-25.5,;-8.43,-27.04,;-7.11,-24.71,;-5.78,-25.48,;-5.78,-27.02,;-4.44,-27.79,;-3.11,-27.02,;-1.78,-27.79,;-1.78,-29.33,;-.46,-30.08,;-3.11,-30.1,;-4.44,-29.33,;-4.44,-24.71,;-4.44,-23.17,;-3.11,-25.48,;-1.77,-24.71,;-1.77,-23.17,;-.43,-22.4,;-.43,-20.86,;.91,-23.17,;-.43,-25.48,;-.43,-27.02,;.9,-24.71,;2.23,-25.49,;2.23,-27.03,;3.56,-27.8,;4.9,-27.01,;3.56,-29.34,;3.56,-24.72,;3.56,-23.18,;4.9,-25.48,;6.24,-24.71,;6.24,-23.17,;7.58,-22.4,;7.58,-20.86,;8.91,-23.17,;7.58,-25.48,;7.58,-27.02,;8.91,-24.72,;10.25,-25.49,;10.24,-27.03,;11.58,-27.81,;11.57,-29.35,;12.91,-27.04,;11.58,-24.72,;11.58,-23.18,;12.92,-25.49,;14.25,-24.73,;14.25,-23.19,;12.92,-22.42,;15.55,-22.39,;15.59,-25.5,;15.59,-27.04,;16.91,-24.7,;18.23,-25.48,;18.23,-27.02,;19.57,-27.79,;19.57,-29.33,;20.91,-30.09,;20.94,-31.63,;19.57,-32.37,;22.25,-32.38,;19.57,-24.71,;19.57,-23.17,;20.91,-25.47,;22.26,-24.72,;22.26,-23.18,;23.6,-22.41,;23.6,-20.87,;22.25,-20.08,;24.93,-20.1,;23.6,-25.49,;23.6,-27.03,;24.92,-24.71,;26.25,-25.49,;26.25,-27.03,;27.59,-27.8,;27.59,-29.34,;28.93,-30.1,;28.94,-31.64,;27.59,-32.39,;30.27,-32.4,;27.59,-24.72,;27.59,-23.18,;28.92,-25.49,;30.26,-24.72,;30.26,-23.18,;31.6,-22.41,;32.93,-23.18,;34.26,-22.41,;34.26,-20.87,;35.6,-20.1,;32.93,-20.1,;31.6,-20.87,;31.6,-25.49,;31.6,-27.03,;32.93,-24.72,;34.26,-25.49,;34.26,-27.03,;35.6,-27.8,;35.59,-24.72,;36.93,-25.49,;35.59,-23.18,)|
Show InChI InChI=1S/C84H136N28O20S/c1-41(2)30-56(99-46(10)114)73(124)101-53(15-12-28-96-83(90)91)71(122)109-62(36-49-38-94-40-98-49)78(129)108-60(34-47-17-21-50(115)22-18-47)76(127)104-58(32-43(5)6)75(126)110-63(37-66(86)118)79(130)105-57(31-42(3)4)74(125)106-59(33-44(7)8)80(131)112-67(45(9)113)81(132)103-54(16-13-29-97-84(92)93)69(120)102-55(25-26-65(85)117)72(123)100-52(14-11-27-95-82(88)89)70(121)107-61(35-48-19-23-51(116)24-20-48)77(128)111-64(39-133)68(87)119/h17-24,38,40-45,52-64,67,113,115-116,133H,11-16,25-37,39H2,1-10H3,(H2,85,117)(H2,86,118)(H2,87,119)(H,94,98)(H,99,114)(H,100,123)(H,101,124)(H,102,120)(H,103,132)(H,104,127)(H,105,130)(H,106,125)(H,107,121)(H,108,129)(H,109,122)(H,110,126)(H,111,128)(H,112,131)(H4,88,89,95)(H4,90,91,96)(H4,92,93,97)/t45-,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,64+,67+/m1/s1
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
>1.00E+3n/an/an/an/an/an/an/an/a



Bayer Pharmaceuticals Corporation

Curated by ChEMBL


Assay Description
Displacement of [125I]PYY from human NPY5 receptor in HEK293 cells


Bioorg Med Chem Lett 17: 1916-9 (2007)


Article DOI: 10.1016/j.bmcl.2007.01.045
BindingDB Entry DOI: 10.7270/Q2WW7HB0
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 1


(Homo sapiens (Human))
BDBM50205094
PNG
((S)-2-((S)-2-((2S,3R)-2-((S)-2-((S)-2-((S)-2-((S)-...)
Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(N)=O |wU:4.4,78.81,45.46,95.96,23.22,61.62,115.116,77.78,wD:33.33,12.11,84.85,53.54,104.105,69.70,127.129,(-16.44,-20.9,;-16.44,-22.44,;-15.11,-23.21,;-17.79,-23.21,;-17.79,-24.75,;-19.12,-25.52,;-20.46,-24.75,;-21.79,-25.52,;-20.46,-23.21,;-16.44,-25.52,;-16.44,-27.06,;-15.12,-24.73,;-13.8,-25.51,;-13.8,-27.05,;-12.45,-27.82,;-12.45,-29.36,;-11.11,-30.11,;-11.12,-31.65,;-12.47,-32.41,;-9.78,-32.42,;-12.45,-24.74,;-12.45,-23.2,;-11.11,-25.49,;-9.77,-24.73,;-9.77,-23.19,;-8.43,-22.42,;-7.03,-23.06,;-5.99,-21.91,;-6.76,-20.58,;-8.27,-20.89,;-8.43,-25.5,;-8.43,-27.04,;-7.11,-24.71,;-5.78,-25.48,;-5.78,-27.02,;-4.44,-27.79,;-3.11,-27.02,;-1.78,-27.79,;-1.78,-29.33,;-.46,-30.08,;-3.11,-30.1,;-4.44,-29.33,;-4.44,-24.71,;-4.44,-23.17,;-3.11,-25.48,;-1.77,-24.71,;-1.77,-23.17,;-.43,-22.4,;-.43,-20.86,;.91,-23.17,;-.43,-25.48,;-.43,-27.02,;.9,-24.71,;2.23,-25.49,;2.23,-27.03,;3.56,-27.8,;4.9,-27.01,;3.56,-29.34,;3.56,-24.72,;3.56,-23.18,;4.9,-25.48,;6.24,-24.71,;6.24,-23.17,;7.58,-22.4,;7.58,-20.86,;8.91,-23.17,;7.58,-25.48,;7.58,-27.02,;8.91,-24.72,;10.25,-25.49,;10.24,-27.03,;11.58,-27.81,;11.57,-29.35,;12.91,-27.04,;11.58,-24.72,;11.58,-23.18,;12.92,-25.49,;14.25,-24.73,;14.25,-23.19,;12.92,-22.42,;15.55,-22.39,;15.59,-25.5,;15.59,-27.04,;16.91,-24.7,;18.23,-25.48,;18.23,-27.02,;19.57,-27.79,;19.57,-29.33,;20.91,-30.09,;20.94,-31.63,;19.57,-32.37,;22.25,-32.38,;19.57,-24.71,;19.57,-23.17,;20.91,-25.47,;22.26,-24.72,;22.26,-23.18,;23.6,-22.41,;23.6,-20.87,;22.25,-20.08,;24.93,-20.1,;23.6,-25.49,;23.6,-27.03,;24.92,-24.71,;26.25,-25.49,;26.25,-27.03,;27.59,-27.8,;27.59,-29.34,;28.93,-30.1,;28.94,-31.64,;27.59,-32.39,;30.27,-32.4,;27.59,-24.72,;27.59,-23.18,;28.92,-25.49,;30.26,-24.72,;30.26,-23.18,;31.6,-22.41,;32.93,-23.18,;34.26,-22.41,;34.26,-20.87,;35.6,-20.1,;32.93,-20.1,;31.6,-20.87,;31.6,-25.49,;31.6,-27.03,;32.93,-24.72,;34.26,-25.49,;34.26,-27.03,;35.6,-27.8,;35.59,-24.72,;36.93,-25.49,;35.59,-23.18,)|
Show InChI InChI=1S/C84H136N28O20S/c1-41(2)30-56(99-46(10)114)73(124)101-53(15-12-28-96-83(90)91)71(122)109-62(36-49-38-94-40-98-49)78(129)108-60(34-47-17-21-50(115)22-18-47)76(127)104-58(32-43(5)6)75(126)110-63(37-66(86)118)79(130)105-57(31-42(3)4)74(125)106-59(33-44(7)8)80(131)112-67(45(9)113)81(132)103-54(16-13-29-97-84(92)93)69(120)102-55(25-26-65(85)117)72(123)100-52(14-11-27-95-82(88)89)70(121)107-61(35-48-19-23-51(116)24-20-48)77(128)111-64(39-133)68(87)119/h17-24,38,40-45,52-64,67,113,115-116,133H,11-16,25-37,39H2,1-10H3,(H2,85,117)(H2,86,118)(H2,87,119)(H,94,98)(H,99,114)(H,100,123)(H,101,124)(H,102,120)(H,103,132)(H,104,127)(H,105,130)(H,106,125)(H,107,121)(H,108,129)(H,109,122)(H,110,126)(H,111,128)(H,112,131)(H4,88,89,95)(H4,90,91,96)(H4,92,93,97)/t45-,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,64+,67+/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
>1.00E+3n/an/an/an/an/an/an/an/a



Bayer Pharmaceuticals Corporation

Curated by ChEMBL


Assay Description
Displacement of [125I]PYY from human NPY1 receptor in SK-N-MC cells


Bioorg Med Chem Lett 17: 1916-9 (2007)


Article DOI: 10.1016/j.bmcl.2007.01.045
BindingDB Entry DOI: 10.7270/Q2WW7HB0
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50205094
PNG
((S)-2-((S)-2-((2S,3R)-2-((S)-2-((S)-2-((S)-2-((S)-...)
Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(N)=O |wU:4.4,78.81,45.46,95.96,23.22,61.62,115.116,77.78,wD:33.33,12.11,84.85,53.54,104.105,69.70,127.129,(-16.44,-20.9,;-16.44,-22.44,;-15.11,-23.21,;-17.79,-23.21,;-17.79,-24.75,;-19.12,-25.52,;-20.46,-24.75,;-21.79,-25.52,;-20.46,-23.21,;-16.44,-25.52,;-16.44,-27.06,;-15.12,-24.73,;-13.8,-25.51,;-13.8,-27.05,;-12.45,-27.82,;-12.45,-29.36,;-11.11,-30.11,;-11.12,-31.65,;-12.47,-32.41,;-9.78,-32.42,;-12.45,-24.74,;-12.45,-23.2,;-11.11,-25.49,;-9.77,-24.73,;-9.77,-23.19,;-8.43,-22.42,;-7.03,-23.06,;-5.99,-21.91,;-6.76,-20.58,;-8.27,-20.89,;-8.43,-25.5,;-8.43,-27.04,;-7.11,-24.71,;-5.78,-25.48,;-5.78,-27.02,;-4.44,-27.79,;-3.11,-27.02,;-1.78,-27.79,;-1.78,-29.33,;-.46,-30.08,;-3.11,-30.1,;-4.44,-29.33,;-4.44,-24.71,;-4.44,-23.17,;-3.11,-25.48,;-1.77,-24.71,;-1.77,-23.17,;-.43,-22.4,;-.43,-20.86,;.91,-23.17,;-.43,-25.48,;-.43,-27.02,;.9,-24.71,;2.23,-25.49,;2.23,-27.03,;3.56,-27.8,;4.9,-27.01,;3.56,-29.34,;3.56,-24.72,;3.56,-23.18,;4.9,-25.48,;6.24,-24.71,;6.24,-23.17,;7.58,-22.4,;7.58,-20.86,;8.91,-23.17,;7.58,-25.48,;7.58,-27.02,;8.91,-24.72,;10.25,-25.49,;10.24,-27.03,;11.58,-27.81,;11.57,-29.35,;12.91,-27.04,;11.58,-24.72,;11.58,-23.18,;12.92,-25.49,;14.25,-24.73,;14.25,-23.19,;12.92,-22.42,;15.55,-22.39,;15.59,-25.5,;15.59,-27.04,;16.91,-24.7,;18.23,-25.48,;18.23,-27.02,;19.57,-27.79,;19.57,-29.33,;20.91,-30.09,;20.94,-31.63,;19.57,-32.37,;22.25,-32.38,;19.57,-24.71,;19.57,-23.17,;20.91,-25.47,;22.26,-24.72,;22.26,-23.18,;23.6,-22.41,;23.6,-20.87,;22.25,-20.08,;24.93,-20.1,;23.6,-25.49,;23.6,-27.03,;24.92,-24.71,;26.25,-25.49,;26.25,-27.03,;27.59,-27.8,;27.59,-29.34,;28.93,-30.1,;28.94,-31.64,;27.59,-32.39,;30.27,-32.4,;27.59,-24.72,;27.59,-23.18,;28.92,-25.49,;30.26,-24.72,;30.26,-23.18,;31.6,-22.41,;32.93,-23.18,;34.26,-22.41,;34.26,-20.87,;35.6,-20.1,;32.93,-20.1,;31.6,-20.87,;31.6,-25.49,;31.6,-27.03,;32.93,-24.72,;34.26,-25.49,;34.26,-27.03,;35.6,-27.8,;35.59,-24.72,;36.93,-25.49,;35.59,-23.18,)|
Show InChI InChI=1S/C84H136N28O20S/c1-41(2)30-56(99-46(10)114)73(124)101-53(15-12-28-96-83(90)91)71(122)109-62(36-49-38-94-40-98-49)78(129)108-60(34-47-17-21-50(115)22-18-47)76(127)104-58(32-43(5)6)75(126)110-63(37-66(86)118)79(130)105-57(31-42(3)4)74(125)106-59(33-44(7)8)80(131)112-67(45(9)113)81(132)103-54(16-13-29-97-84(92)93)69(120)102-55(25-26-65(85)117)72(123)100-52(14-11-27-95-82(88)89)70(121)107-61(35-48-19-23-51(116)24-20-48)77(128)111-64(39-133)68(87)119/h17-24,38,40-45,52-64,67,113,115-116,133H,11-16,25-37,39H2,1-10H3,(H2,85,117)(H2,86,118)(H2,87,119)(H,94,98)(H,99,114)(H,100,123)(H,101,124)(H,102,120)(H,103,132)(H,104,127)(H,105,130)(H,106,125)(H,107,121)(H,108,129)(H,109,122)(H,110,126)(H,111,128)(H,112,131)(H4,88,89,95)(H4,90,91,96)(H4,92,93,97)/t45-,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,64+,67+/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 160n/an/an/an/a



Bayer Pharmaceuticals Corporation

Curated by ChEMBL


Assay Description
Agonist activity at human NPY2 receptor in KAN-TS cells by [35S]GTPgammaS binding assay


Bioorg Med Chem Lett 17: 1916-9 (2007)


Article DOI: 10.1016/j.bmcl.2007.01.045
BindingDB Entry DOI: 10.7270/Q2WW7HB0
More data for this
Ligand-Target Pair